Researchers highlight the unprecedented success of GLP-1-based multi-receptor drugs in achieving substantial weight loss and improved health outcomes, potentially replacing bariatric surgery for obesity treatment.
GLP-1-based polyagonists: A promising weight loss alternative to bariatric surgery
- Post author:
- Post published:July 28, 2024
- Post category:uncategorized